Segmentation of the Pathophysiological Stages of Diabetic Changes in the db/db Mouse

Area of Science:

• Biomedical Research
• Animal Models
• Endocrinology

Background:

• The db/db mouse is a widely used model for studying diabetes mellitus.
• Understanding the pathophysiological progression in this model is crucial for evaluating therapeutic interventions.
• Previous studies have established the db/db mouse as a model for type 2 diabetes, but detailed staging of its progression remains important.

Purpose of the Study:

• To determine the pathophysiological stages of diabetic changes in the db/db mouse model.
• To assess the similarity of these stages to human diabetes.
• To validate the db/db mouse as a suitable model for evaluating drug candidates for diabetes.

Main Methods:

• Longitudinal evaluation of db/db mice from 6 to 22 weeks of age.
• Measurement of plasma insulin and HbA1c (hemoglobin A1c) levels at various time points.
• Histopathological examination of pancreatic islets to assess morphology and cellular changes.

Main Results:

• At 6 weeks, db/db mice exhibited high insulin, low HbA1c, and enlarged, hypertrophic islets.
• By 9-12 weeks, insulin decreased, HbA1c increased, and a mix of enlarged circular and small irregular islets were observed.
• By 15-22 weeks, insulin was low, HbA1c was high, and small, irregular islets predominated.

Conclusions:

• The db/db mouse model demonstrates distinct pathophysiological stages of diabetes mellitus.
• These stages, characterized by changes in insulin, HbA1c, and islet morphology, closely mimic human diabetic progression.
• The db/db mouse is a valuable preclinical model for assessing the efficacy of diabetes drug candidates.